In a panel of 352 gastric cancer patients, high MTBP protein levels were associated with improved patient survival (multivariate analysis hazard ratio 0.633, 95% confidence interval [CI] 0.417–0.961, p = 0.032) with low levels of MTBP being associated with higher rates of both lymph node (n = 273, odds ratio [OR] 0.282, 95% CI 0.161–0.494, p < 0.001) and distant metastases (n = 48, OR 0.365, 95% CI 0.138–0.965, p = 0.042) [111]. This evidence concerns the gene MTBP and gastric cancer.